The Significance of Ferroptosis in Renal Diseases and Its Therapeutic Potential

Overview

Journal Heliyon

Specialty Social Sciences

Date 2024 Sep 2

PMID 39220983

Authors

Mingzhu Jiang

Shujun Wu

Kun Xie

Gang Zhou

Wei Zhou

Ping Bao

Affiliations

Soon will be listed here.

Abstract

Kidney diseases are significant global public health concern, with increasing prevalence and substantial economic impact. Developing novel therapeutic approaches are essential for delaying disease progression and improving patient quality of life. Cell death signifying the termination of cellular life, could facilitate appropriate bodily development and internal homeostasis. Recently, regulated cell death (RCD) forms such as ferroptosis, characterized by iron-dependent lipid peroxidation, has garnered attention in diverse renal diseases and other pathological conditions. This review offers a comprehensive examination of ferroptosis, encompassing an analysis of the involvement of iron and lipid metabolism, the System Xc /glutathione/glutathione peroxidase 4 signaling, and additional associated pathways. Meanwhile, the review delves into the potential of targeting ferroptosis as a therapeutic approach in the management of acute kidney injury (AKI), chronic kidney disease (CKD), diabetic nephropathy, and renal tumors. Furthermore, it emphasizes the significance of ferroptosis in the transition from AKI to CKD and further accentuates the potential for repurposing drug and utilizing traditional medicine in targeting ferroptosis-related pathways for clinical applications. The integrated review provides valuable insights into the role of ferroptosis in kidney diseases and highlights the potential for targeting ferroptosis as a therapeutic strategy.

References

Tan S, Mahmud I, Fontanesi F, Puchowicz M, Neumann C, Griswold A . Obesity-Dependent Adipokine Chemerin Suppresses Fatty Acid Oxidation to Confer Ferroptosis Resistance. Cancer Discov. 2021; 11(8):2072-2093. PMC: 8338847. DOI: 10.1158/2159-8290.CD-20-1453. View

Su L, Jiang X, Yang C, Zhang J, Chen B, Li Y . Pannexin 1 mediates ferroptosis that contributes to renal ischemia/reperfusion injury. J Biol Chem. 2019; 294(50):19395-19404. PMC: 6916502. DOI: 10.1074/jbc.RA119.010949. View

Han C, Liu Y, Dai R, Ismail N, Su W, Li B . Ferroptosis and Its Potential Role in Human Diseases. Front Pharmacol. 2020; 11:239. PMC: 7090218. DOI: 10.3389/fphar.2020.00239. View

Kim S, Kang S, Joo J, Han S, Shin H, Nam B . Characterization of ferroptosis in kidney tubular cell death under diabetic conditions. Cell Death Dis. 2021; 12(2):160. PMC: 7870666. DOI: 10.1038/s41419-021-03452-x. View

Li Y, Ran Q, Duan Q, Jin J, Wang Y, Yu L . 7-Dehydrocholesterol dictates ferroptosis sensitivity. Nature. 2024; 626(7998):411-418. PMC: 11298758. DOI: 10.1038/s41586-023-06983-9. View

Liang C, Zhang X, Yang M, Dong X . Recent Progress in Ferroptosis Inducers for Cancer Therapy. Adv Mater. 2019; 31(51):e1904197. DOI: 10.1002/adma.201904197. View

Bayir H, Dixon S, Tyurina Y, Kellum J, Kagan V . Ferroptotic mechanisms and therapeutic targeting of iron metabolism and lipid peroxidation in the kidney. Nat Rev Nephrol. 2023; 19(5):315-336. DOI: 10.1038/s41581-023-00689-x. View

Lo Y, Yang S, Cheng C, Hsu K, Chen Y, Chen Y . Nobiletin Alleviates Ferroptosis-Associated Renal Injury, Inflammation, and Fibrosis in a Unilateral Ureteral Obstruction Mouse Model. Biomedicines. 2022; 10(3). PMC: 8944974. DOI: 10.3390/biomedicines10030595. View

Linkermann A, Skouta R, Himmerkus N, Mulay S, Dewitz C, De Zen F . Synchronized renal tubular cell death involves ferroptosis. Proc Natl Acad Sci U S A. 2014; 111(47):16836-41. PMC: 4250130. DOI: 10.1073/pnas.1415518111. View

10.

Stamenkovic A, Pierce G, Ravandi A . Phospholipid oxidation products in ferroptotic myocardial cell death. Am J Physiol Heart Circ Physiol. 2019; 317(1):H156-H163. DOI: 10.1152/ajpheart.00076.2019. View

11.

Fang D, Wang Y, Zhang Z, Yang D, Gu D, He B . Calorie Restriction Protects against Contrast-Induced Nephropathy via SIRT1/GPX4 Activation. Oxid Med Cell Longev. 2021; 2021:2999296. PMC: 8548166. DOI: 10.1155/2021/2999296. View

12.

Kobayashi S, Homma T, Okumura N, Han J, Nagaoka K, Sato H . Carnosine dipeptidase II (CNDP2) protects cells under cysteine insufficiency by hydrolyzing glutathione-related peptides. Free Radic Biol Med. 2021; 174:12-27. DOI: 10.1016/j.freeradbiomed.2021.07.036. View

13.

Zheng B, Niu Z, Si S, Zhao G, Wang J, Yao Z . Comprehensive analysis of new prognostic signature based on ferroptosis-related genes in clear cell renal cell carcinoma. Aging (Albany NY). 2021; 13(15):19789-19804. PMC: 8386570. DOI: 10.18632/aging.203390. View

14.

Granata S, Votrico V, Spadaccino F, Catalano V, Netti G, Ranieri E . Oxidative Stress and Ischemia/Reperfusion Injury in Kidney Transplantation: Focus on Ferroptosis, Mitophagy and New Antioxidants. Antioxidants (Basel). 2022; 11(4). PMC: 9024672. DOI: 10.3390/antiox11040769. View

15.

DellAtti L, Bianchi N, Aguiari G . New Therapeutic Interventions for Kidney Carcinoma: Looking to the Future. Cancers (Basel). 2022; 14(15). PMC: 9332391. DOI: 10.3390/cancers14153616. View

16.

Moore P, Hsu R, Liu K . Management of Acute Kidney Injury: Core Curriculum 2018. Am J Kidney Dis. 2018; 72(1):136-148. DOI: 10.1053/j.ajkd.2017.11.021. View

17.

Tang S, Xiao X . Ferroptosis and kidney diseases. Int Urol Nephrol. 2019; 52(3):497-503. DOI: 10.1007/s11255-019-02335-7. View

18.

Yang J, Zhou Y, Li Y, Hu W, Yuan C, Chen S . Functional deficiency of succinate dehydrogenase promotes tumorigenesis and development of clear cell renal cell carcinoma through weakening of ferroptosis. Bioengineered. 2022; 13(4):11187-11207. PMC: 9278435. DOI: 10.1080/21655979.2022.2062537. View

19.

Wettersten H, Abu Aboud O, Lara Jr P, Weiss R . Metabolic reprogramming in clear cell renal cell carcinoma. Nat Rev Nephrol. 2017; 13(7):410-419. DOI: 10.1038/nrneph.2017.59. View

20.

Lin C, Tseng H, Hsieh P, Chiu V, Lin T, Lan C . Nephroprotective Role of Chrysophanol in Hypoxia/Reoxygenation-Induced Renal Cell Damage via Apoptosis, ER Stress, and Ferroptosis. Biomedicines. 2021; 9(9). PMC: 8467645. DOI: 10.3390/biomedicines9091283. View